Skip to main content
. 2020 Oct 26;56(6):106214. doi: 10.1016/j.ijantimicag.2020.106214

Table 6.

Co-medications of patients in the treatment group

Drug class Patients [n (%) of N = 141]
Beta-blockers 17 (12)
Angiotensin-converting enzyme inhibitors 8 (6)
Angiotensin 2 antagonists 13 (9)
Calcium channel blockers 8 (6)
Hydrochlorothiazide 6 (4)
Statins 28 (20)
Bronchodilators 10 (7)
Antidiabetics 11 (8)
Insulin 26 (18)
Oral corticosteroids 13 (9)
Antibiotics 3 (2)